436 related articles for article (PubMed ID: 17550134)
1. Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status.
Minutilli E; Giannarelli D; Anzà M; Garinei R; Perri P; Botti C; Piarulli L; Bruno P; Rea S; Visca R; Mottolese M; Di Filippo S; Di Filippo F
J Exp Clin Cancer Res; 2007 Mar; 26(1):71-6. PubMed ID: 17550134
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
5. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
[TBL] [Abstract][Full Text] [Related]
6. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
Cascinelli N; Bombardieri E; Bufalino R; Camerini T; Carbone A; Clemente C; Lenisa L; Mascheroni L; Maurichi A; Pennacchioli E; Patuzzo R; Santinami M; Tragni G
J Clin Oncol; 2006 Sep; 24(27):4464-71. PubMed ID: 16983115
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
8. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.
Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886
[TBL] [Abstract][Full Text] [Related]
9. [Influence of selected clinical features on detection of sentinel node in patients with skin melanoma].
Nejc D; Piekarski J; Jeziorski A
Przegl Lek; 2005; 62(12):1427-30. PubMed ID: 16786765
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance.
Gennari R; Bartolomei M; Testori A; Zurrida S; Stoldt HS; Audisio RA; Geraghty JG; Paganelli G; Veronesi U
Surgery; 2000 Jan; 127(1):19-25. PubMed ID: 10660754
[TBL] [Abstract][Full Text] [Related]
12. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
[TBL] [Abstract][Full Text] [Related]
13. High negative predictive value of slow lymphatic drainage on metastatic node spread detection in malignant limb and trunk cutaneous melanoma.
Cammilleri S; Jacob T; Rojat-Habib MC; Hesse S; Berthet B; Giorgi R; Bonerandi JJ; Mundler O
Bull Cancer; 2004; 91(7-8):E225-8. PubMed ID: 15381460
[TBL] [Abstract][Full Text] [Related]
14. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
15. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
[TBL] [Abstract][Full Text] [Related]
16. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients.
Matter M; Nicod Lalonde M; Allaoua M; Boubaker A; Liénard D; Gugerli O; Cerottini JP; Bouzourene H; Bischof Delaloye A; Lejeune F
J Nucl Med; 2007 Oct; 48(10):1607-13. PubMed ID: 17873127
[TBL] [Abstract][Full Text] [Related]
17. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
18. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
19. Ratio of marked and excised sentinel lymph nodes and scintigraphic appearance time in melanoma patients with negative sentinel lymph node.
Richtig E; Komericki P; Trapp M; Ott A; Bisail B; Egger JW; Zalaudek I
Eur J Surg Oncol; 2010 Aug; 36(8):783-8. PubMed ID: 20510570
[TBL] [Abstract][Full Text] [Related]
20. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
Sumner WE; Ross MI; Mansfield PF; Lee JE; Prieto VG; Schacherer CW; Gershenwald JE
Cancer; 2002 Jul; 95(2):354-60. PubMed ID: 12124836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
